Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation
- PMID: 20378673
- DOI: 10.1093/jac/dkq116
Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation
Similar articles
-
Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.J Clin Microbiol. 2009 May;47(5):1613. doi: 10.1128/JCM.00404-09. J Clin Microbiol. 2009. PMID: 19403778 Free PMC article. No abstract available.
-
Tigecycline for the treatment of Acinetobacter infections: a case series.Ann Pharmacother. 2008 Sep;42(9):1188-94. doi: 10.1345/aph.1L171. Ann Pharmacother. 2008. PMID: 18614749
-
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i29-40. doi: 10.1093/jac/dkn249. J Antimicrob Chemother. 2008. PMID: 18684704 Clinical Trial.
-
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:198-202. doi: 10.1111/j.1469-0691.2007.01852.x. Clin Microbiol Infect. 2008. PMID: 18154548 Review.
-
Therapeutic options for Acinetobacter baumannii infections.Expert Opin Pharmacother. 2008 Mar;9(4):587-99. doi: 10.1517/14656566.9.4.587. Expert Opin Pharmacother. 2008. PMID: 18312160 Review.
Cited by
-
Tigecycline treatment of urinary tract infection and prostatitis: case report and literature review.Can J Hosp Pharm. 2012 May;65(3):209-15. doi: 10.4212/cjhp.v65i3.1144. Can J Hosp Pharm. 2012. PMID: 22783032 Free PMC article. No abstract available.
-
Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort.Clin Ther. 2012 Jun;34(6):1314-23. doi: 10.1016/j.clinthera.2012.05.002. Clin Ther. 2012. PMID: 22691610 Free PMC article.
-
Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.Drugs. 2022 Mar;82(4):407-438. doi: 10.1007/s40265-022-01676-5. Epub 2022 Mar 14. Drugs. 2022. PMID: 35286622 Free PMC article. Review.
-
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14. Clin Microbiol Rev. 2014. PMID: 24982323 Free PMC article. Review.
-
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.Drugs. 2014 Aug;74(12):1315-33. doi: 10.1007/s40265-014-0267-8. Drugs. 2014. PMID: 25091170 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical